Duffield Jeremy 4
4 · Prime Medicine, Inc. · Filed Apr 4, 2023
Insider Transaction Report
Form 4
Duffield Jeremy
Chief Scientific Officer
Transactions
- Award
Stock Option (right to buy)
2023-03-31+180,995→ 180,995 totalExercise: $12.30Exp: 2033-03-31→ Common Stock (180,995 underlying)
Footnotes (1)
- [F1]1/48th of the shares underlying this option vest and become exercisable in substantially equal monthly installments on each monthly anniversary of March 31, 2023, subject to the Reporting Person's continued service on each such vesting date.